Eyenovia Inc
NASDAQ:EYEN
Eyenovia Inc
Depreciation & Amortization
Eyenovia Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eyenovia Inc
NASDAQ:EYEN
|
Depreciation & Amortization
-$783.2k
|
CAGR 3-Years
-99%
|
CAGR 5-Years
-108%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
-$9.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-183%
|
CAGR 10-Years
-70%
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
-$4.9B
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Eyenovia Inc's Depreciation & Amortization?
Depreciation & Amortization
-783.2k
USD
Based on the financial report for Dec 31, 2023, Eyenovia Inc's Depreciation & Amortization amounts to -783.2k USD.
What is Eyenovia Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-108%
Over the last year, the Depreciation & Amortization growth was -153%. The average annual Depreciation & Amortization growth rates for Eyenovia Inc have been -99% over the past three years , -108% over the past five years .